Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse Management”

189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 189 results

Large-scale testing (Phase 3)Study completedNCT01707992
What this trial is testing

The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 2,199
Testing effectiveness (Phase 2)Study completedNCT03754634
What this trial is testing

A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP

Who this might be right for
Thrombocytopenia
Shandong University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05674175
What this trial is testing

Co-administration of CART22-65s and huCART19 for B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB Lineage Lymphoblastic Lymphoma
Stephan Grupp MD PhD 93
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT04083495
What this trial is testing

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center 20
Not applicableLooking for participantsNCT06464016
What this trial is testing

Complications in Pediatric Mechanical Circulatory Assistance: Evaluation of Infection Management.

Who this might be right for
Heart-Assist DevicesInfectionsHeart Transplant Infection
Claude Bernard University 47
Post-approval studies (Phase 4)Study completedNCT00362193
What this trial is testing

Glycemic Relapse Prevention: Maintenance Dose Assessment

Who this might be right for
Type 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 165
Early research (Phase 1)WithdrawnNCT00674141
What this trial is testing

Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment

Who this might be right for
MS Patient With Relpasing Remitting Attacks
Hadassah Medical Organization 10
Not applicableStudy completedNCT00902135
What this trial is testing

Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Bayer 702
Testing effectiveness (Phase 2)Looking for participantsNCT05972135
What this trial is testing

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 100
Not applicableLooking for participantsNCT06551519
What this trial is testing

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 700
Not applicableActive Not RecruitingNCT03993665
What this trial is testing

Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis

Who this might be right for
Head and Neck CancerMultiparametric MRICervical Lymph Node+3 more
AZ Sint-Jan AV 70
Testing effectiveness (Phase 2)Looking for participantsNCT07234019
What this trial is testing

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Testing effectiveness (Phase 2)Study completedNCT00395317
What this trial is testing

Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 343
Testing effectiveness (Phase 2)Study completedNCT01778010
What this trial is testing

Modafinil for Smoked Cocaine Self-Administration

Who this might be right for
Cocaine Dependence
New York State Psychiatric Institute 8
Early research (Phase 1)Study completedNCT04139434
What this trial is testing

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

Who this might be right for
AML/MDSCMMLRelapse+3 more
Newave Pharmaceutical Inc 32
Not applicableUnknownNCT00192751
What this trial is testing

From Compliance to Alliance: Engaging Psychiatric Patients in Illness Management

Who this might be right for
Patients Diagnosed With Severe Mental Illness
Rambam Health Care Campus 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07503340
What this trial is testing

Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Hoffmann-La Roche 25
Testing effectiveness (Phase 2)Ended earlyNCT00100737
What this trial is testing

Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin Lymphoma
Chiron Corporation 300
Not applicableNot Yet RecruitingNCT06949956
What this trial is testing

Administration of Fingolimod in Greek Patients With Multiple Sclerosis.

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Elpen Pharmaceutical Co. Inc. 140
Load More Results